{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:27:48Z","timestamp":1787030868910,"version":"build-2736575974"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"name":"COI stream and SRIP grant from MEXT"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The adaptive transfer of T cells redirected to cancer cells via chimeric Ag receptors (CARs) has produced clinical benefits for the treatment of hematologic diseases. To extend this approach to solid cancer, we screened CARs targeting surface Ags on human lung cancer cells using (to our knowledge) novel expression cloning based on the Ag receptor-induced transcriptional activation of IL-2. Isolated CARs were directed against fragile X mental retardation 1 neighbor (FMR1NB), a cancer-testis Ag that is expressed by malignant cells and adult testicular germ cells. Anti-FMR1NB CAR human T cells demonstrated target-specific cytotoxicity and successfully controlled tumor growth in mouse xenograft models of lung cancer. Furthermore, to protect CAR T cells from immune-inhibitory molecules, which are present in the tumor microenvironment, we introduced anti-FMR1NB CARs into 2-deoxy-glucose (2DG)\u2013treated human T cells. These cells exhibited reduced binding affinity to immune-inhibitory molecules, and the suppressive effects of these molecules were resisted through blockade of the N-glycosylation of their receptors. Anti-FMR1NB CARs in 2DG-treated human T cells augmented target-specific cytotoxicity in vitro and in vivo. Thus, our findings demonstrated the feasibility of eradicating lung cancer cells using 2DG-treated human T cells, which are able to direct tumor-specific FMR1NB via CARs and survive in the suppressive tumor microenvironment.<\/jats:p>","DOI":"10.4049\/jimmunol.2300618","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T09:54:27Z","timestamp":1705053267000},"page":"917-927","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy against Lung Cancer Is Augmented by Combining Aberrantly\n                    <i>N<\/i>\n                    -Glycosylated T Cells with a Chimeric Antigen Receptor Targeting Fragile X Mental Retardation 1 Neighbor"],"prefix":"10.1093","volume":"212","author":[{"given":"Toshihiko","family":"Toyofuku","sequence":"first","affiliation":[{"name":"Department of Immunology and Molecular Medicine, Graduate School of Medicine, The Center of Medical Innovation and Translational Research, Osaka University , Suita, Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Immunology and Molecular Medicine, Graduate School of Medicine, The Center of Medical Innovation and Translational Research, Osaka University , Suita, Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Nojima","sequence":"additional","affiliation":[{"name":"Department of Pathology, Graduate School of Medicine, Osaka University , Suita, Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kumanogoh","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University , Suita, Osaka ,","place":["Japan"]},{"name":"Laboratory of Immunopathology, WPI Immunology Frontier Research Center, Osaka University , Suita, Osaka ,","place":["Japan"]},{"name":"Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University , Suita, Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,12]]},"reference":[{"key":"2025020405452817300_r1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"2025020405452817300_r2","doi-asserted-by":"crossref","first-page":"177ra38","DOI":"10.1126\/scitranslmed.3005930","article-title":"CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia","volume":"5","author":"Brentjens","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"2025020405452817300_r3","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","article-title":"Chimeric antigen receptor-modified T cells for acute lymphoid leukemia","volume":"368","author":"Grupp","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"2025020405452817300_r4","doi-asserted-by":"crossref","first-page":"95ra73","DOI":"10.1126\/scitranslmed.3002842","article-title":"T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia","volume":"3","author":"Kalos","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"2025020405452817300_r5","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1103849","article-title":"Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia","volume":"365","author":"Porter","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"2025020405452817300_r6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fimmu.2019.00128","article-title":"CAR T cells for solid tumors: new strategies for finding, infiltrating, and surviving in the tumor microenvironment","volume":"10","author":"Martinez","year":"2019","journal-title":"Front. Immunol."},{"key":"2025020405452817300_r7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jtho.2017.10.001","article-title":"Chimeric antigen receptor (CAR) T-cell therapy for thoracic malignancies. [Published erratum appears in 2018 J. Thorac. Oncol. 13: 1229.]","volume":"13","author":"Kiesgen","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"2025020405452817300_r8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.coi.2012.12.003","article-title":"T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment","volume":"25","author":"Crespo","year":"2013","journal-title":"Curr. Opin. Immunol."},{"key":"2025020405452817300_r9","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrclinonc.2017.88","article-title":"Monitoring immune-checkpoint blockade: response evaluation and biomarker development","volume":"14","author":"Nishino","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2025020405452817300_r10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0191-1","article-title":"Immune checkpoint inhibitors: recent progress and potential biomarkers","volume":"50","author":"Darvin","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"2025020405452817300_r11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3389\/fonc.2014.00385","article-title":"CTLA-4 and PD-1 pathway blockade: combinations in the clinic","volume":"4","author":"Callahan","year":"2015","journal-title":"Front. Oncol."},{"key":"2025020405452817300_r12","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"2025020405452817300_r13","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nrm3383","article-title":"Vertebrate protein glycosylation: diversity, synthesis and function","volume":"13","author":"Moremen","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2025020405452817300_r14","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/nri2417","article-title":"Mammalian glycosylation in immunity","volume":"8","author":"Marth","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"2025020405452817300_r15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ni.f.203","article-title":"Protein-glycan interactions in the control of innate and adaptive immune responses","volume":"9","author":"van Kooyk","year":"2008","journal-title":"Nat. Immunol."},{"key":"2025020405452817300_r16","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.4049\/jimmunol.1900937","article-title":"Blockade of N-glycosylation promotes antitumor immune response of T cells","volume":"204","author":"Sasawatari","year":"2020","journal-title":"J. Immunol."},{"key":"2025020405452817300_r17","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3389\/fimmu.2016.00530","article-title":"Functionally diverse NK-like T cells are effectors and predictors of successful aging","volume":"7","author":"Michel","year":"2016","journal-title":"Front. Immunol."},{"key":"2025020405452817300_r18","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1073\/pnas.0437972100","article-title":"Immunomic analysis of human sarcoma","volume":"100","author":"Lee","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025020405452817300_r19","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrc1669","article-title":"Cancer\/testis antigens, gametogenesis and cancer","volume":"5","author":"Simpson","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"2025020405452817300_r20","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1002\/bit.26266","article-title":"Site-specific monitoring of N-glycosylation profiles of a CTLA4-Fc-fusion protein from the secretory pathway to the extracellular environment","volume":"114","author":"Bora de Oliveira","year":"2017","journal-title":"Biotechnol. Bioeng."},{"key":"2025020405452817300_r21","doi-asserted-by":"crossref","first-page":"14369","DOI":"10.1038\/ncomms14369","article-title":"An unexpected N-terminal loop in PD-1 dominates binding by nivolumab","volume":"8","author":"Tan","year":"2017","journal-title":"Nat. Commun."},{"key":"2025020405452817300_r22","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1158\/0008-5472.CAN-19-3133","article-title":"Targeting glycosylated PD-1 induces potent antitumor immunity","volume":"80","author":"Sun","year":"2020","journal-title":"Cancer Res."},{"key":"2025020405452817300_r23","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nrc3565","article-title":"Gene-engineered T cells for cancer therapy","volume":"13","author":"Kershaw","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"2025020405452817300_r24","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1248\/bpb.29.1570","article-title":"Creation of novel protein transduction domain (PTD) mutants by a phage display-based high-throughput screening system","volume":"29","author":"Mukai","year":"2006","journal-title":"Biol. Pharm. Bull."},{"key":"2025020405452817300_r25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0952-7915(95)80107-3","article-title":"Transcriptional regulation of the IL-2 gene","volume":"7","author":"Jain","year":"1995","journal-title":"Curr. Opin. Immunol."},{"key":"2025020405452817300_r26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-1-4939-7659-1_18","article-title":"Flow cytometric identification of tumor-infiltrating lymphocytes from glioblastoma","volume":"1741","author":"Woroniecka","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"2025020405452817300_r27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2013.01.004","article-title":"Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy","volume":"38","author":"Liao","year":"2013","journal-title":"Immunity"},{"key":"2025020405452817300_r28","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/ni1002-903","article-title":"Sweet \u2018n\u2019 sour: the impact of differential glycosylation on T cell responses","volume":"3","author":"Daniels","year":"2002","journal-title":"Nat. Immunol."},{"key":"2025020405452817300_r29","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"2025020405452817300_r30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood-2017-06-741033","article-title":"CTLA-4: a moving target in immunotherapy","volume":"131","author":"Rowshanravan","year":"2018","journal-title":"Blood"},{"key":"2025020405452817300_r31","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1089\/ars.2007.1714","article-title":"Differential toxic mechanisms of 2-deoxy-d-glucose versus 2-fluorodeoxy-d-glucose in hypoxic and normoxic tumor cells","volume":"9","author":"Kurtoglu","year":"2007","journal-title":"Antioxid. Redox Signal."},{"key":"2025020405452817300_r32","first-page":"2069","article-title":"PD-1 and PD-L1 up-regulation promotes T-cell apoptosis in gastric adenocarcinoma","volume":"38","author":"Chiu","year":"2018","journal-title":"Anticancer Res."},{"key":"2025020405452817300_r33","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nm.2232","article-title":"Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF","volume":"16","author":"Quigley","year":"2010","journal-title":"Nat. Med."},{"key":"2025020405452817300_r34","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/35105024","article-title":"T-cell regulation by CD28 and CTLA-4","volume":"1","author":"Alegre","year":"2001","journal-title":"Nat. Rev. Immunol."},{"key":"2025020405452817300_r35","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1073\/pnas.90.2.720","article-title":"Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors","volume":"90","author":"Eshhar","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025020405452817300_r36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/PPO.0000000000000032","article-title":"CAR T cells for solid tumors: armed and ready to go?","volume":"20","author":"Kakarla","year":"2014","journal-title":"Cancer J."},{"key":"2025020405452817300_r37","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1002\/ddr.21184","article-title":"Assays and strategies for immunogenicity assessment of biological agents","volume":"75","author":"Nencini","year":"2014","journal-title":"Drug Dev. Res."},{"key":"2025020405452817300_r38","doi-asserted-by":"crossref","first-page":"217","DOI":"10.59566\/IJBS.2006.2217","article-title":"Immunoassay methods and their applications in pharmaceutical analysis: basic methodology and recent advances","volume":"2","author":"Darwish","year":"2006","journal-title":"Int. J. Biomed. Sci."},{"key":"2025020405452817300_r39","doi-asserted-by":"crossref","first-page":"e105602","DOI":"10.1371\/journal.pone.0105602","article-title":"Cell surface profiling using high-throughput flow cytometry: a platform for biomarker discovery and analysis of cellular heterogeneity. [Published erratum appears in 2014 PLoS One 9: e114354.]","volume":"9","author":"Gedye","year":"2014","journal-title":"PLoS One"},{"key":"2025020405452817300_r40","doi-asserted-by":"crossref","first-page":"314","DOI":"10.2353\/ajpath.2009.080893","article-title":"Epigenetic modulation of cancer-germline antigen gene expression in tumorigenic human mesenchymal stem cells: implications for cancer therapy","volume":"175","author":"Gjerstorff","year":"2009","journal-title":"Am. J. Pathol."},{"key":"2025020405452817300_r41","doi-asserted-by":"crossref","first-page":"15772","DOI":"10.18632\/oncotarget.4694","article-title":"Oncogenic cancer\/testis antigens: prime candidates for immunotherapy","volume":"6","author":"Gjerstorff","year":"2015","journal-title":"Oncotarget"},{"key":"2025020405452817300_r42","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.3389\/fimmu.2020.01568","article-title":"CAR T-cell cancer therapy targeting surface cancer\/testis antigens","volume":"11","author":"Jakobsen","year":"2020","journal-title":"Front. Immunol."},{"key":"2025020405452817300_r43","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13045-019-0793-7","article-title":"MAGE-A1 in lung adenocarcinoma as a promising target of chimeric antigen receptor T cells","volume":"12","author":"Mao","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"2025020405452817300_r44","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.3389\/fimmu.2018.02754","article-title":"Glycans as key checkpoints of T cell activity and function","volume":"9","author":"Pereira","year":"2018","journal-title":"Front. Immunol."},{"key":"2025020405452817300_r45","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nri.2018.3","article-title":"The tumour glyco-code as a novel immune checkpoint for immunotherapy","volume":"18","author":"Rodr\u00cdguez","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"2025020405452817300_r46","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.canlet.2014.09.003","article-title":"2-Deoxy-d-glucose targeting of glucose metabolism in cancer cells as a potential therapy","volume":"355","author":"Zhang","year":"2014","journal-title":"Cancer Lett."},{"key":"2025020405452817300_r47","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.tibs.2016.11.003","article-title":"Translating the \u201csugar code\u201d into immune and vascular signaling programs","volume":"42","author":"Cerliani","year":"2017","journal-title":"Trends Biochem. Sci."},{"key":"2025020405452817300_r48","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nri2536","article-title":"Turning \u201csweet\u201d on immunity: galectin-glycan interactions in immune tolerance and inflammation","volume":"9","author":"Rabinovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"2025020405452817300_r49","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1084\/jem.194.10.1485","article-title":"CD8\u03b2 endows CD8 with efficient coreceptor function by coupling T cell receptor\/CD3 to raft-associated CD8\/p56lck complexes","volume":"194","author":"Arcaro","year":"2001","journal-title":"J. Exp. Med."},{"key":"2025020405452817300_r50","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1074-7613(03)00019-0","article-title":"Quantitative analysis of the contribution of TCR\/pepMHC affinity and CD8 to T cell activation","volume":"18","author":"Holler","year":"2003","journal-title":"Immunity"},{"key":"2025020405452817300_r51","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/35055582","article-title":"Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation","volume":"409","author":"Demetriou","year":"2001","journal-title":"Nature"},{"key":"2025020405452817300_r52","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.0105-2896.2010.00905.x","article-title":"The transcriptional control of the perforin locus","volume":"235","author":"Pipkin","year":"2010","journal-title":"Immunol. Rev."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/212\/5\/917\/61474210\/ji2300618.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/212\/5\/917\/61474210\/ji2300618.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:48:03Z","timestamp":1738630083000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/212\/5\/917\/7925981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,12]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,3,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.2300618","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3]]},"published":{"date-parts":[[2024,1,12]]}}}